Factors prognostic of survival in advanced-stage uterine serous carcinoma.

Factors prognostic of survival in advanced-stage uterine serous carcinoma.
复制标题

晚期子宫浆液性癌生存的预后因素。

DOI:
10.1016/j.ygyno.2017.04.018
复制
发表时间:
2017-07
影响因子:
4.7
通讯作者:
Westin SN
Westin SN
中科院分区:
医学2区
文献类型:
--
作者:
Holman LL;Pal N;Iglesias DA;Soliman PT;Balakrishnan N;Klopp A;Broaddus RR;Fleming ND;Munsell MF;Lu KH;Westin SN

文献摘要

参考文献

被引文献

相似文献

The study objective was to analyze the impact of prognostic factors, including treatment modality, on outcome in patients with advanced-stage uterine serous carcinoma (USC). A retrospective review of patients diagnosed with stage III or IV USC between 1993 and 2012 was performed. Summary statistics were used to describe demographic and clinical characteristics. Overall survival (OS) and recurrence free survival (RFS) were estimated by Kaplan-Meier analysis. Cox proportional hazards regression was used to model the association of potential prognostic factors with OS and RFS. The study included 260 patients with median follow-up of 26.6 months (range 1–172.8). Median age was 63 years (range 30–88) and 52.3% had stage III disease. In all, 60% were treated with surgery followed by chemotherapy, 18.1% received surgery, chemotherapy, and radiotherapy, 11.5% had surgery and radiotherapy, and 10.4% had neoadjuvant chemotherapy. The overall complete response rate was 68.9%, and the cumulative incidence of recurrence was 82.7%. Treatment that included surgery, chemotherapy, and radiation and stage III disease were associated with improved RFS on multivariate analysis. For OS, therapy with surgery, chemotherapy, and radiation, mixed histology, and stage III disease were associated with better OS on multivariate analysis. Patients with advanced-stage USC have a poor prognosis, regardless of clinical factors or treatment received. However, combination therapy that includes chemotherapy and radiation appears to be associated with improved survival in these women.
DOI: 10.1006/gyno.2000.6110
发表时间: 2001-04-01
影响因子: 4.7
作者:
Bristow, RE;Duska, LR;Montz, FJ
通讯作者: Montz, FJ
DOI: 10.1016/j.ygyno.2013.10.035
发表时间: 2014-01-01
影响因子: 4.7
作者:
Lee, Larissa J.;De Maria, Rebecca;Viswanathan, Akila N.
通讯作者: Viswanathan, Akila N.
DOI: 10.1002/cncr.24247
发表时间: 2009-05-15
期刊: CANCER
影响因子: 6.2
作者:
Fader, Amanda Nickles;Drake, Richard D.;Zanotti, Kristine M.
通讯作者: Zanotti, Kristine M.
DOI: 10.1016/j.ygyno.2007.06.014
发表时间: 2007-11-01
影响因子: 4.7
作者:
Secord, Angeles Alvarez;Havrilesky, Laura J.;Gehrig, Paola A.
通讯作者: Gehrig, Paola A.
DOI: 10.1016/j.ygyno.2010.07.010
发表时间: 2010-11-01
影响因子: 4.7
作者:
Rauh-Hain, J. Alejandro;Growdon, Whitfield B.;del Carmen, Marcela G.
通讯作者: del Carmen, Marcela G.